Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score–matched cohort

[1]  J. Douglas.  Current state of the roles of alcohol septal ablation and surgical myectomy in the treatment of hypertrophic obstructive cardiomyopathy. , 2020, Cardiovascular diagnosis and therapy.

[2]  I. Meredith,et al.  Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience. , 2017, Heart, lung & circulation.

[3]  H. Schaff,et al.  Long-Term Mortality Effect of Early Pacemaker Implantation After Surgical Aortic Valve Replacement. , 2017, The Annals of thoracic surgery.

[4]  H. Schaff,et al.  Hypertrophic Obstructive Cardiomyopathy: Surgical Myectomy and Septal Ablation , 2017, Circulation research.

[5]  H. Schaff,et al.  Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience. , 2017, Annals of cardiothoracic surgery.

[6]  M. Arguis,et al.  Septal myectomy after failed septal alcohol ablation. , 2017, Annals of cardiothoracic surgery.

[7]  C. Grines,et al.  Septal Ablation and Hypertrophic Obstructive Cardiomyopathy: 7 Years US Experience. , 2016, Journal of interventional cardiology.

[8]  C. Glover,et al.  A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  H. Bundgaard,et al.  Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry. , 2016, European heart journal.

[10]  N. Smedira,et al.  Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction. , 2015, Journal of the American College of Cardiology.

[11]  S. Ommen,et al.  Septal myectomy after failed alcohol ablation: Does previous percutaneous intervention compromise outcomes of myectomy? , 2015, The Journal of thoracic and cardiovascular surgery.

[12]  F. T. ten Cate,et al.  Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy. , 2014, JACC. Heart failure.

[13]  M. P. van den Berg,et al.  Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience. , 2014, JACC. Cardiovascular interventions.

[14]  C. Grines,et al.  Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from Nationwide Inpatient Sample [1998-2010]). , 2014, The American journal of cardiology.

[15]  F. Rutten,et al.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.

[16]  D. Walters,et al.  VALVULAR AND STRUCTURAL HEART DISEASES Original Studies The Long-Term Outcomes of Transcoronary Ablation of Septal Hypertrophy Compared to Surgical Myectomy in Patients with Symptomatic Hypertrophic Obstructive Cardiomyopathy , 2014 .

[17]  Ellen Aagaard Nohr,et al.  Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark , 2013, European heart journal.

[18]  H. Schaff,et al.  Surgical treatment of hypertrophic cardiomyopathy. , 2013, Seminars in thoracic and cardiovascular surgery.

[19]  B. Gersh,et al.  Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy , 2012, Circulation.

[20]  Karel G M Moons,et al.  Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. , 2012, Heart rhythm.

[21]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[22]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[23]  Barry J Maron,et al.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, The Journal of thoracic and cardiovascular surgery.

[24]  P. Serruys,et al.  Long-Term Outcome of Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy: A Word of Caution , 2010, Circulation. Heart failure.

[25]  I. Palacios,et al.  Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. , 2009, The American journal of cardiology.

[26]  B. Gersh,et al.  Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy , 2008, Circulation.

[27]  S. Ommen,et al.  Septal myectomy after previous septal artery ablation in hypertrophic cardiomyopathy. , 2007, Mayo Clinic proceedings.

[28]  B. Maron.  Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy , 2007 .

[29]  A. Tajik,et al.  Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[30]  T. Sundt,et al.  Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. , 2005, Journal of the American College of Cardiology.

[31]  A. Tajik,et al.  Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. , 2004, Journal of the American College of Cardiology.

[32]  S. Ommen,et al.  Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. , 2001, Journal of the American College of Cardiology.

[33]  K. Bailey,et al.  Hypertrophic obstructive cardiomyopathy: preoperative echocardiographic predictors of outcome after septal myectomy. , 1996, Journal of the American College of Cardiology.

[34]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[35]  U. Sigwart.  Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy , 1995, The Lancet.

[36]  B. Gersh,et al.  Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[37]  B. Maron.  Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. , 2007, Circulation.